TRIMERO Diagnostics offers, under the brand KLoneus®, IVD CE marked nephelometric assays for testing FREE LIGHT CHAINS (FLC) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.
Medium and high bind Krystal microplates from Porvair Sciences set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as Enzyme-Linked Immunosorbent Assay (ELISA). Manufactured from high-quality crystal polystyrene – these new automation-ready plates are available in a choice of ANSI / SLAS standard (96-well […]
Greiner Bio-One has introduced VACUETTE FC Mix Tube for effective glycolysis inhibition for precise determination of the in vivo blood sugar content.
The time from collection until separation of plasma and cells, temperature as well as cell count strongly affect glucose levels possibly leading to false low results. Unfortunately, fluoride alone is not able to stabilize the real in-vivo glucose level completely.
VACUETTE FC Mix Tubes are citrated and therefore can help to prevent the initial loss of glucose within the first few hours from collection until fluoride shows its effect. Buffered Na2EDTA, citric acid, sodium citrate and sodium fluoride are used to decrease the pH and block the pH dependent enzymes, which would be active in the initial stage of the glycolysis cascade.
SEKISUI Diagnostics has launched the OSOM Ultra Plus Flu A&B Test. The test utilizes traditional lateral flow technology with performance near or exceeding sensitivity of other reader-based tests without using an instrument. It is intended for the qualitative detection of influenza type A and type B nucleoprotein antigens directly from nasal or nasopharyngeal swab specimens from patients with signs and symptoms of respiratory infection.
High performance, point-of-care rapid test for the detection of Influenza A&B
TRIMERO Diagnostics offers IVD CE marked assays for testing IgD Immunoglobulins (IgD) on Beckman Coulter’s IMMAGE® Immunochemical Systems and Siemens’ BN™ nephelometric systems.
In response to the ongoing COVID-19 pandemic, Erba Mannheim has launched the ErbaMDx SARS-CoV-2 RT-PCR Kit for detection of SARS-CoV-2.
To overcome challenges in older COVID-19 molecular tests, Erba’s Cambridge(UK)-based development team has engineered a new assay to improve detection and ease of use with a single tube multiplex mastermix, compatible with room-temperature storage and transportation.
The new assay offers 200 copies/ml LoD, using universally trusted gene targets highly specific for SARS-CoV-2 and updated primer sequences to maximise long term performance. Sample types include both nasopharyngeal and oropharyngeal swabs as well as saliva.
Nikhil Vazirani, MD of Erba, said: “We are proud and excited to add a highly sensitive RT-PCR test to our growing range of immunoassay and molecular solutions. The new ErbaMDx SARS-CoV-2 test perfectly complements our successful COVID-19 IgG and IgM ELISA assays to offer customers a state-of-the-art molecular test in addition to antibody testing which will offer clinicians valuable insight into the immune response to infection or vaccination.”
The CE-marked kit will be available through Erba’s global distribution network.
Erba Mannheim, established in over 100 countries, focusses on delivering innovative, affordable and sustainable diagnostic solutions to labs everywhere. The Erba group uses a combination of cutting-edge R&D in 4 continents with efficient low-cost manufacturing to make diagnostic technologies accessible in all resource settings.
Siemens Healthineers announced 7 January that the U.S. FDA has issued an Emergency Use Authorization (EUA) for their laboratory-based IL-6 assay to measure the presence of Interleukin-6 (IL-6) in human serum or plasma. IL-6 is an indicator of potential severe inflammatory response in patients with confirmed SARS-CoV-2 infection. Emergency use of this test is limited […]
ZTA Biotech, a Budapest-based biotech start-up, announced 6 January the breakthrough development of a COVID-19 antibody (IgG) test using the ELISA protocol – and is offering the intellectual property rights to licensees or a sole-rights purchaser.
DiaSys has introduced cartridge-based rapid tests for the detection of COVID-19 antigens and IgM and IgG antibodies, Influenza A&B as well as SGTi-flex COVID-19 & Flu A/B Ag DUO. These rapid tests are easy and reliable to use and provide accurate results within a short time. Besides providing quick access to test results, rapid tests […]
Hologic’s new Genius Digital Diagnostics System is now CE marked in Europe. Genius Digital Diagnostics is the first digital cytology platform to combine a new artificial intelligence (AI) algorithm with advanced digital imaging to help cytotechnologists and pathologists identify precancerous lesions and cancer cells in women.
December 2020 / January 2021
Parklaan 54a
5613 BH
Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.